Cabozantinib,Nivolumab,Ipilimumab
Exelixis,bms
['triplet,(-triplete)', 'cosmic313']
also fewer deep responses on the triplet arm, which is a bit surprising. why does this matter? well, showed that it's the deep responses that may carry out to protracted pfs and os in #cosmic313. this data was presented at 2022. #esmo22(8/10 
@cityofhope & @cityofhopeoc prof w focus on #kidneycancer, #prostatecancer, #bladdercancer & 90s rock. RTs not endorsements. COI: https://t.co/L7ihnCjLz5